Market Overview:
The global osteoporosis testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of osteoporosis, rising geriatric population, and technological advancements in the field of osteoporosis diagnosis. The global osteoporosis testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into dexa-scan, FRAX tool, CT scans, X-rays,, ultrasounds,, and others. On the basis of application,.the market is segmented into hospitals,, orthopedic clinics,, ambulatory surgical centers,.and others. Geographically,.the global osteoporosis testing market is divided into North America., Latin America., Europe., Asia Pacific., and Middle East & Africa. Some key players operating in thismarket are Siemens Healthcare GmbH (Germany), Hologic Inc.(U.S.), GE Healthcare (U.K.), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation(Japan), Shimadzu Corporation(Japan), Carestream Health Inc.(U.S.
Product Definition:
Osteoporosis is a medical condition in which bones become weak and brittle. Osteoporosis Testing is the process of diagnosing this condition. The importance of Osteoporosis Testing is that it can help identify people at risk for developing osteoporosis, so they can take steps to prevent the disease from occurring.
Dexa-Scan:
Dexa-Scan is a radiographic bone density test that measures the amount of calcium and phosphate in the body. The test helps to detect osteoporosis which is caused by loss of bone mass. Dexa-scanning machines are used for measuring BMD (bone mineral density) levels which further help in diagnosing diseases such as osteoporosis, anemia, cancer, and other disorders related to bones & muscle.
FRAX tool:
Osteoporosis Testing market, by Type: Globally FRAX tool is used for osteoporosis testing in men and women. It helps to measure the bone mineral density of patients. The test is performed on the hip or spine as it is easy to obtain a sample from these areas. However, this test can only detect if a person has low bone mass; it cannot diagnose osteoporosis itself.
Application Insights:
Based on application, the global osteoporosis testing market is segmented into hospitals, orthopedic clinics and ambulatory surgical centers. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities along with a large number of patients suffering from bone fractures. In addition, these institutions have highly skilled medical staffs that can conduct diagnostic procedures efficiently.
Osteoporosis testing is considered essential for women above 50 years as well as men who have suffered from hip fractures or osteoarthritis pain in their joints due to low bone mass or fragility bones.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high awareness levels coupled with relatively higher healthcare expenditure and prevalence of osteoporosis are some factors responsible for its large share. Moreover, increasing R&D investments by companies and government to develop novel osteoporosis testing devices is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare facilities in emerging economies such as India & China along with growing investment by governments & private players for developing advanced diagnostic technologies at affordable costs. Growing geriatric population base, rising incidences of bone disorders due to sedentary lifestyle and changing dietary habits will also support regional growth during the same period (2018 - 2030).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for osteoporosis testing products and services.
- Rising awareness about osteoporosis: There is a growing awareness among people about the risks associated with osteoporosis and this is likely to boost the demand for osteoporosis testing products and services in the coming years.
- Growing incidence of fractures due to osteoporosis: The incidence of fractures due to osteoporosis is on the rise globally and this is expected to create a strong demand for diagnostic tests and treatments for osteoporosis in the near future.
- Technological advancements in diagnostics: There have been significant advancements in diagnostic technologies over the past few years that are helping healthcare professionals detect early signs of bone loss, which can lead to development of osteoporosis later in life. This is likely to fuel growth prospects for the global market for osteproros testing products and services in coming years. 5) rising adoption rates of preventive measures against bone loss: A growing number of people are adopting preventive measures against bone loss such as regular exercise, balanced diet, etc., which will help increase uptake ratesforosteporposis testingproductsand servicesthroughoutthe forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Osteoporosis Testing Market Research Report
By Type
Dexa-Scan, FRAX tool, CT scans, X-rays, Ultrasounds, Others
By Application
Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers
By Companies
GE Healthcare, Merck, B.M.Tech. Worldwide, DMS Imaging, Swissray, Hologic, Pfizer, CompuMed, Eli Lilly
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Osteoporosis Testing Market Report Segments:
The global Osteoporosis Testing market is segmented on the basis of:
Types
Dexa-Scan, FRAX tool, CT scans, X-rays, Ultrasounds, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Merck
- B.M.Tech. Worldwide
- DMS Imaging
- Swissray
- Hologic
- Pfizer
- CompuMed
- Eli Lilly
Highlights of The Osteoporosis Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dexa-Scan
- FRAX tool
- CT scans
- X-rays
- Ultrasounds
- Others
- By Application:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Osteoporosis Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Osteoporosis testing is a medical procedure used to measure the degree of bone loss in the body. The test can help identify potential risk factors for osteoporosis and may also provide information about the effectiveness of treatment.
Some of the key players operating in the osteoporosis testing market are GE Healthcare, Merck, B.M.Tech. Worldwide, DMS Imaging, Swissray, Hologic, Pfizer, CompuMed, Eli Lilly.
The osteoporosis testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Osteoporosis Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Osteoporosis Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Osteoporosis Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Osteoporosis Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Osteoporosis Testing Market Size & Forecast, 2018-2028
4.5.1 Osteoporosis Testing Market Size and Y-o-Y Growth
4.5.2 Osteoporosis Testing Market Absolute $ Opportunity
Chapter 5 Global Osteoporosis Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Osteoporosis Testing Market Size Forecast by Type
5.2.1 Dexa-Scan
5.2.2 FRAX tool
5.2.3 CT scans
5.2.4 X-rays
5.2.5 Ultrasounds
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Osteoporosis Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Osteoporosis Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Orthopedic Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Osteoporosis Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Osteoporosis Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Osteoporosis Testing Analysis and Forecast
9.1 Introduction
9.2 North America Osteoporosis Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Osteoporosis Testing Market Size Forecast by Type
9.6.1 Dexa-Scan
9.6.2 FRAX tool
9.6.3 CT scans
9.6.4 X-rays
9.6.5 Ultrasounds
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Osteoporosis Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Orthopedic Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Osteoporosis Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Osteoporosis Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Osteoporosis Testing Market Size Forecast by Type
10.6.1 Dexa-Scan
10.6.2 FRAX tool
10.6.3 CT scans
10.6.4 X-rays
10.6.5 Ultrasounds
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Osteoporosis Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Orthopedic Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Osteoporosis Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Osteoporosis Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Osteoporosis Testing Market Size Forecast by Type
11.6.1 Dexa-Scan
11.6.2 FRAX tool
11.6.3 CT scans
11.6.4 X-rays
11.6.5 Ultrasounds
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Osteoporosis Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Orthopedic Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Osteoporosis Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Osteoporosis Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Osteoporosis Testing Market Size Forecast by Type
12.6.1 Dexa-Scan
12.6.2 FRAX tool
12.6.3 CT scans
12.6.4 X-rays
12.6.5 Ultrasounds
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Osteoporosis Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Orthopedic Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Osteoporosis Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Osteoporosis Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Osteoporosis Testing Market Size Forecast by Type
13.6.1 Dexa-Scan
13.6.2 FRAX tool
13.6.3 CT scans
13.6.4 X-rays
13.6.5 Ultrasounds
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Osteoporosis Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Orthopedic Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Osteoporosis Testing Market: Competitive Dashboard
14.2 Global Osteoporosis Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Merck
14.3.3 B.M.Tech. Worldwide
14.3.4 DMS Imaging
14.3.5 Swissray
14.3.6 Hologic
14.3.7 Pfizer
14.3.8 CompuMed
14.3.9 Eli Lilly
